Showing results (41-50 of 157) with videos related to
Sort By:
Pageof 16
Journal of Participatory Medicine|October 14, 2020
Patient and Family Involvement: A Discussion of Co-Led Redesign of Healthcare ServicesSarah Jane Prior, Steven CampbellUrologic Oncology|July 22, 2014
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohortLaura-Maria Krabbe, Robert S Svatek, Shahrokh F Shariat, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 16, 2017
Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumoursMatthew Truong, Lorraine Liang, Janet Kukreja, et al.Urologic Oncology|May 5, 2010
BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progressVictoria L Robinson, Michael Porter, Edward Messing, et al.Clinical Genitourinary Cancer|February 23, 2020
The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?Emily Lemke, Deepak Sahasrabudhe, Elizabeth Guancial, et al.Female Pelvic Medicine & Reconstructive Surgery|July 30, 2019
Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial CarcinomaLioudmila Lipetskaia, Toy Gee Lee, Dongmei Li, et al.Frontiers in Immunology|April 29, 2026
Bacillus Calmette-Guérin immunotherapy-induced extracellular vesicles promote antitumor immunity in bladder cancerCarlos J Ortiz-Bonilla, Ryan D Molony, Hiroshi Miyamoto, et al.Comprehensive Child and Adolescent Nursing|August 25, 2018
Healthcare Professionals' Views of the Experiences of Children With Cancer and Their Families Living in Tasmania: An Interpretive-Descriptive StudyJessica Hammersley, Karen Ford, Steven CampbellJAMA|January 19, 2006
Surveillance for recurrent bladder cancer using a point-of-care proteomic assayH Barton Grossman, Mark Soloway, Edward Messing, et al.JAMA|February 17, 2005
Detection of bladder cancer using a point-of-care proteomic assayH Barton Grossman, Edward Messing, Mark Soloway, et al.Pageof 16